Pitch Perfect Presentations

Dr. Joshua Chu-Tan is a postdoctoral fellow at the John Curtin School of Medical Research and lecturer at the Australian National University Medical School in Canberra, Australia. Josh’s research focuses on the use of microRNA as gene therapeutics for retinal degenerations, with a specific focus on age-related macular degeneration (AMD), the leading cause of blindness in the developed world. His work in the field has been published in top-ranked ophthalmology and vision science journals. He also served as an intern editor, blog writer, and advisor at world-leading academic publishing company, Springer Nature. Josh’s passion for science communication has earned him numerous awards for conference presentations and public speaking events and competitions, including first prize at the Asia-Pacific 3 Minute Thesis, and A.T. Kearney Scholar/Finalist for YoungInnovator of the Year at the prestigious Falling Walls Conference and Lab in Berlin, Germany.

Dr. Joshua Chu-Tan is a postdoctoral fellow at the John Curtin School of Medical Research and lecturer at the Australian National University Medical School in Canberra, Australia. Josh’s research focuses on the use of microRNA as gene therapeutics for retinal degenerations, with a specific focus on age-related macular degeneration (AMD), the leading cause of blindness in the developed world. His work in the field has been published in top-ranked ophthalmology and vision science journals. He also served as an intern editor, blog writer, and advisor at world-leading academic publishing company, Springer Nature. Josh’s passion for science communication has earned him numerous awards for conference presentations and public speaking events and competitions, including first prize at the Asia-Pacific 3 Minute Thesis, and A.T. Kearney Scholar/Finalist for YoungInnovator of the Year at the prestigious Falling Walls Conference and Lab in Berlin, Germany.